Cleared Traditional

K223640 - Axoguard HA+ Nerve Protector (AGHA12) (FDA 510(k) Clearance)

Also includes:
Axoguard HA+ Nerve Protector (AGHA22) Axoguard HA+ Nerve Protector (AGHA24) Axoguard HA+ Nerve Protector (AGHA36) Axoguard HA+ Nerve Protector (AGHA48)
Apr 2023
Decision
123d
Days
Class 2
Risk

K223640 is an FDA 510(k) clearance for the Axoguard HA+ Nerve Protector (AGHA12). This device is classified as a Cuff, Nerve (Class II - Special Controls, product code JXI).

Submitted by Axogen Corporation (Alachua, US). The FDA issued a Cleared decision on April 7, 2023, 123 days after receiving the submission on December 5, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5275.

Submission Details

510(k) Number K223640 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2022
Decision Date April 07, 2023
Days to Decision 123 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code JXI - Cuff, Nerve
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5275